Systemic mastocytosis with acute myelomonocytic leukemia: a case report

Case Report
  • 44 Downloads

Abstract

Bone marrow mastocytosis may be associated with many clonal non mast cell hematological neoplasms and its association with acute myeloid leukemia especially with t (8; 21) has been described. We describe an interesting case of coexistence of systemic mastocytosis with acute myelomonocytic leukemia in a young child. Diagnosis of acute myelomonocytic leukemia was based on bone marrow aspirate findings coupled with cytochemistry. Systemic mastocytosis was diagnosed on the basis of bone marrow biopsy findings showing blasts as well as multifocal dense mast cell infiltrates with spindling and atypical morphology which was confirmed on toluidine blue staining.

Keywords

Acute myeloid leukemia Toluidine blue Systemic mastocytosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Valent P, Horny HP, Li CY, Longley BJ, Metcalfe DD, Parwaresch RM, Bennet JM (2001) Mastocytosis. In World Health Organization classification of Tumors. Pathology and Genetics of tumors of hematopoetic and lymphoid tissues. Lyon, IARC Press, pp 293–302Google Scholar
  2. 2.
    Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK (2003) Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 73(1): 12–17PubMedCrossRefGoogle Scholar
  3. 3.
    Bernd HW, Sotlar K, Lorenzen J, Osieka R, Fabry U, Valent P, Horny HP (2004) Acute myeloid leukaemia with t(8;21) associated with “occult” mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 57(3): 324–328PubMedCrossRefGoogle Scholar
  4. 4.
    Sperr WR, Drach J, Hauswirth AW, Ackermann J, Mitterbauer M, Mitterbauer G, Foedinger M, Fonatsch C, Simonitsch-Klupp I, Kalhs P, Valent P (2005) Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 11(19 Pt 1):6787–6792PubMedCrossRefGoogle Scholar
  5. 5.
    Escribano L, Garca-Montero A, Núñez-López R, López-Jiménez J, Almeida J, Prados A, Orfao A (2004) Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis. J Allergy Clin Immunol 114(1):28–33PubMedCrossRefGoogle Scholar
  6. 6.
    Pullarkat V, Bedell V, Kim Y, Bhatia R, Nakamura R, Forman S, Sun J, Senitzer D, Slovak ML (2007) Neoplastic mast cells in systemic mastocytosis associated with t (8; 21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 31(2):261–265. Epub 2006 Jul 28PubMedCrossRefGoogle Scholar
  7. 7.
    Varma N, Varma S, Wilkins B (2000) Acute myeloblastic leukaemia with differentiation to myeloblasts and mast cell blasts. Br J Haematol 111(4):991. Erratum in: Br J Haematol 2001;112(4):1091PubMedCrossRefGoogle Scholar
  8. 8.
    Horny HP, Sotlar K, Sperr WR, Valent P (2004) Systemic mastocytosis with associated clonal haematological nonmast cell lineage diseases: a histopathological challenge. J Clin Pathol 57(6):604–608PubMedCrossRefGoogle Scholar
  9. 9.
    Adhya AK, Varma N, Varma S (2007) Acute myeloid leukemia (AML-M2) with mast cell hyperplasia of bone marrow: a report of three cases. Indian J Pathol Microbiol 50(3): 655–658PubMedGoogle Scholar
  10. 10.
    Pullarkat VA, Pullarkat ST, Calverley DC, Brynes RK (2000) Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His. Am J Hematol 65(4):307–309PubMedCrossRefGoogle Scholar
  11. 11.
    Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2007; [Epub ahead of print]Google Scholar
  12. 12.
    Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, et al (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201–1204PubMedCrossRefGoogle Scholar
  13. 13.
    Lahortiga I, Akin C, Cools J, et al (2008) Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion. Haematologica 93:49–56PubMedCrossRefGoogle Scholar
  14. 14.
    Valent P, Akin C, Sperr WR, Mayerhofer M, Födinger M, Fritsche-Polanz R, Sotlar K, Escribano L, Arock M, Horny HP, Metcalfe DD (2005) Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 46(1):35–48PubMedCrossRefGoogle Scholar
  15. 15.
    Quintas-Cardama A, Aribi A, Cortes J, Giles FJ, Kantarjian H, Verstovsek S (2006) Novel approaches in the treatment of systemic mastocytosis. Cancer 107:1429–1439PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Haematology & Transfusion Medicine 2008

Authors and Affiliations

  1. 1.Department of HematologyAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations